Rhea accuses Sushant's sister of forgery over 'bogus' prescription

In a new turn of events over actor Sushant Singh Rajput’s death, actor Rhea Chakraborty has now accused his sister Priyanka Singh of “forgery” over a prescription that allegedly enabled him to access to medication that cannot be prescribed electronically.

Rhea, 28, who was Sushant’s girlfriend, on Monday (September 7) filed a complaint with Mumbai Police in this regard, naming Priyanka and Dr. Tarun Kumar of the Ram Manohar Lohia Hospital, Delhi.

Her complaint states Priyanka had sent Sushant a prescription by Dr. Tarun Kumar and he “appears to have prescribed medication controlled under Narcotic Drugs and Psychotropic Substances Act, 1985 to Sushant without any consultation as mandated by law,” according to news agency ANI.

The complaint further states the “drugs prescribed by the doctor (Dr. Tarun Kumar) were prohibited from being prescribed electronically under the Telemedicine Practice Guidelines, 2020,” and that the prescription appears to be “forged and fabricated”.

It alleges Sushant was referred to as an Out-Patient Department patient in the prescription but he was in Mumbai on June 8, NDTV reported.

Stating so, Rhea has requested Mumbai Police that an FIR be filed against Priyanka, Dr. Tarun Kumar, and others under the IPC, NDPS Act, and Telemedicine Practice Guidelines, terming the prescription as “bogus”.

Related news: Sushant case: AIIMS team conducts viscera test to check for poisoning

Rhea’s complaint is based on the WhatsApp chats between the deceased and his sister from June 8, from which it appears that Priyanka had asked her brother to take Librium, Nexito, and Lonazep, the report said. The three drugs are prescribed for depression and anxiety.

The chat also contradicts Sushant’s family’s claims that they had no knowledge of mental health problems the actor may have been battling, it said.

Sushant Singh Rajput was found dead in his apartment in suburban Bandra on June 14. His girlfriend Rhea, her brother Showik and others are facing multiple probe in this regard by various agencies including CBI, ED, and the Narcotics Control Bureau.